New pill could stop debilitating HAE attacks in their tracks
Disease control
Completed
This study tested an oral medication, BCX4161, to prevent sudden swelling attacks in people with hereditary angioedema (HAE), a rare genetic condition. About 110 adults with HAE type I or II took either a low dose, high dose, or placebo daily for 12 weeks. Researchers tracked how…
Phase: PHASE2, PHASE3 • Sponsor: BioCryst Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 07:23 UTC